Table 2.
Treatment modalities regarding the most common symptoms for the cerebellar mutism syndrome and its relation to cerebellar cognitive and affective function
| Symptom | First-line alternatives | Other options |
|---|---|---|
| Memory problems | Methylphenidate, anticholinerjic agents, dopamine agonist | Atomoxetine, modafinil |
| Attentional problems | Methylphenidate, anticholinerjic agents, amantadine | Atomoxetine, modafinil |
| Executive dysfunction | Methylphenidate, anticholinerjic agents, amantadine | Atomoxetine, modafinil |
| Depression | Selective serotonin reuptake inhibitors | Newer antidepressants, methylphenidate |
| Emotional lability | Antiepileptic ajans (carbamazepine, valproate) | Lamotrigine, Atypical antipsychotics |
| Fatigue | Anticolinerjic ajans, methylphenidate | Atomoxetine, modafinil |
| Poor initiation, apathy | Selective serotonin reuptake inhibitors, Anticolinerjic ajans, amantadine | Methylphenidate, Atomoxetine, modafinil |
| Slowness of information processing | Methylphenidate, anticholinerjic agents | Atomoxetine, modafinil |